TABLE 1.
Microorganism | Inoculum | Segment | Zone of inhibition (mm)
|
Pb | |
---|---|---|---|---|---|
CS1 catheter | CS2 catheter | ||||
S. aureus | 106 | H | 17.7 ± 2.21 | 16.3 ± 0.14 | 0.047 |
106 | V | 16.3 ± 1.40 | 16.4 ± 1.67 | 0.906 | |
108 | H | 16.5 ± 1.60 | 15.2 ± 0.33 | 0.019 | |
108 | V | 15.5 ± 1.10 | 15.0 ± 0.77 | 0.239 | |
S. epidermidis | 106 | H | 18.4 ± 2.24 | 17.9 ± 1.81 | 0.497 |
106 | V | 17.4 ± 1.80 | 16.7 ± 1.14 | 0.311 | |
108 | H | 17.7 ± 1.93 | 16.4 ± 1.06 | 0.073 | |
108 | V | 16.3 ± 1.62 | 15.4 ± 0.80 | 0.087 | |
E. faecalis | 106 | H | 14.4 ± 1.10 | 12.3 ± 1.44 | 0.0003 |
106 | V | 13.5 ± 0.87 | 12.7 ± 0.73 | 0.014 | |
108 | H | 11.8 ± 0.92 | 11.1 ± 1.44 | 0.209 | |
108 | V | 11.7 ± 0.51 | 10.8 ± 0.70 | 0.003 | |
P. aeruginosa | 106 | H | 16.0 ± 0.71 | 14.4 ± 1.77 | 0.012 |
106 | V | 14.2 ± 1.23 | 13.8 ± 1.79 | 0.473 | |
108 | H | 13.9 ± 2.0 | 13.1 ± 2.30 | 0.353 | |
108 | V | 13.0 ± 2.0 | 12.3 ± 2.61 | 0.451 | |
E. cloacae | 106 | H | 9.6 ± 2.13 | 8.2 ± 0.75 | 0.050 |
106 | V | 9.2 ± 1.05 | 8.1 ± 0.55 | 0.006 | |
108 | H | 9.4 ± 1.83 | 8.4 ± 0.80 | 0.084 | |
108 | V | 9.2 ± 1.10 | 8.6 ± 0.55 | 0.102 | |
C. albicans | 106 | H | 13.5 ± 1.29 | 13.0 ± 1.33 | 0.323 |
106 | V | 12.8 ± 0.94 | 12.4 ± 1.35 | 0.441 | |
108 | H | 12.2 ± 0.61 | 11.2 ± 1.04 | 0.011 | |
108 | V | 11.0 ± 0.53 | 10.3 ± 0.67 | 0.006 |
The activities are presented as those produced after 24 h by horizontal (H) or vertical (V) segments of the commercially available and the experimental catheter on agar plates inoculated with a suspension of 106 or 108 microorganisms/ml. Each value represents the mean ± standard deviation for 12 segments.
Two-sample t test. Boldface numbers indicate statistically significant differences.